Cassady Schiller Wealth Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$940 Buy
63
+28
+80% +$456 ﹤0.01% 803
2024
Q3
$670 Hold
35
﹤0.01% 434
2024
Q2
$725 Hold
35
﹤0.01% 439
2024
Q1
$658 Hold
35
﹤0.01% 468
2023
Q4
$505 Buy
35
+1
+3% +$14 ﹤0.01% 420
2023
Q3
$590 Sell
34
-25
-42% -$521 ﹤0.01% 433
2023
Q2
$1.23K Sell
59
-70
-54% -$1.52K ﹤0.01% 434
2023
Q1
$3.03K Hold
129
﹤0.01% 384
2022
Q4
$3.6K Buy
+129
New +$3.3K ﹤0.01% 386
2022
Q1
Sell
-129
Closed -$4K 440
2021
Q4
$4K Buy
+129
New +$4.2K ﹤0.01% 366

Other funds holding OGN

Cassady Schiller Wealth Management's OGN Position: Q4 2024 in Review

Cassady Schiller Wealth Management increased its Organon & Co (OGN) stake by 80% in Q4 2024, buying an estimated $456 and bringing the position to 63 shares worth $940. The position accounts for ﹤0.01% of the portfolio, ranked #803.

Cassady Schiller Wealth Management first reported a position in OGN in Q4 2021 and has held it in 10 quarters since. The position peaked at $4K in Q4 2021. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • Cassady Schiller Wealth Management held 63 shares of Organon & Co worth $940 as of Q4 2024.
  • Cassady Schiller Wealth Management bought 28 Organon & Co shares in Q4 2024, an estimated $456.
  • Organon & Co made up ﹤0.01% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #803 holding.
  • Cassady Schiller Wealth Management first reported a position in Organon & Co in Q4 2021 and has held it in 10 quarters since.
  • Cassady Schiller Wealth Management's Organon & Co position peaked at $4K in Q4 2021.
  • 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.